Nomograms predicting survival and recurrence in colonic cancer in the era of complete mesocolic excision.
Journal
BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
22
07
2018
accepted:
27
02
2019
entrez:
8
8
2019
pubmed:
8
8
2019
medline:
8
8
2019
Statut:
epublish
Résumé
More extensive lymphadenectomy may improve survival after resection of colonic cancer. Nomograms were created predicting overall survival and recurrence for patients who undergo D2-D3 lymph node dissection, and their validity determined. This was a multicentre study of patients with colonic cancer who underwent resection with D2-D3 lymph node dissection in Japan. Inclusion criteria included R0 resection. A training cohort of patients operated on from 2007 to 2008 was analysed to construct prognostic models predicting survival and recurrence. Discrimination and calibration were performed using an external validation cohort from the Japanese colorectal cancer registry (procedures in 2005-2006). The training cohort consisted of 2746 patients. Predictors of survival were: age (hazard ratio (HR) 1·04), female sex (HR 0·71), depth of tumour invasion (HR 1·15, 1·22, 2·96 and 3·14 for T2, T3, T4a and T4b respectively These nomograms could predict survival and recurrence after curative resection of colonic cancer.
Sections du résumé
Background
More extensive lymphadenectomy may improve survival after resection of colonic cancer. Nomograms were created predicting overall survival and recurrence for patients who undergo D2-D3 lymph node dissection, and their validity determined.
Methods
This was a multicentre study of patients with colonic cancer who underwent resection with D2-D3 lymph node dissection in Japan. Inclusion criteria included R0 resection. A training cohort of patients operated on from 2007 to 2008 was analysed to construct prognostic models predicting survival and recurrence. Discrimination and calibration were performed using an external validation cohort from the Japanese colorectal cancer registry (procedures in 2005-2006).
Results
The training cohort consisted of 2746 patients. Predictors of survival were: age (hazard ratio (HR) 1·04), female sex (HR 0·71), depth of tumour invasion (HR 1·15, 1·22, 2·96 and 3·14 for T2, T3, T4a and T4b respectively
Conclusion
These nomograms could predict survival and recurrence after curative resection of colonic cancer.
Identifiants
pubmed: 31388647
doi: 10.1002/bjs5.50167
pii: BJS550167
pmc: PMC6677094
doi:
Substances chimiques
Carcinoembryonic Antigen
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Pagination
539-548Références
J Clin Oncol. 2011 Dec 20;29(36):4796-802
pubmed: 22084366
Br J Surg. 2016 Aug;103(9):1220-9
pubmed: 27222317
Jpn J Clin Oncol. 1998 Feb;28(2):123-8
pubmed: 9544828
Dis Colon Rectum. 2013 Jul;56(7):815-24
pubmed: 23739187
Dis Colon Rectum. 1999 Jul;42(7):921-9
pubmed: 10411440
Ann Surg Oncol. 2003 Apr;10(3):213-8
pubmed: 12679304
Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5
pubmed: 19016817
J Clin Oncol. 2008 Jan 20;26(3):380-5
pubmed: 18202413
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):261-268
pubmed: 28404155
Int J Colorectal Dis. 2014 Jul;29(7):847-52
pubmed: 24798631
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281
Arch Pathol Lab Med. 2000 Jul;124(7):979-94
pubmed: 10888773
J Clin Oncol. 2012 May 20;30(15):1763-9
pubmed: 22473170
Br J Cancer. 1994 Jun;69(6):979-85
pubmed: 8198989
J Gastroenterol. 2001 Mar;36(3):158-65
pubmed: 11291878
J Clin Oncol. 2003 Aug 1;21(15):2912-9
pubmed: 12885809
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Jpn J Clin Oncol. 2012 Jan;42(1):29-35
pubmed: 22102737
Lancet. 2010 Mar 20;375(9719):1030-47
pubmed: 20304247
Lancet Oncol. 2015 Feb;16(2):161-8
pubmed: 25555421
J Natl Cancer Inst. 2007 Mar 21;99(6):433-41
pubmed: 17374833